Pano, Leonila .
HRN: 25-61-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2024
CO-AMOXICLAV 625MG (TAB)
08/04/2024
08/10/2024
PO
1 Tab
BiD
Postpartum NSvd With 3rd Degree Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes